Effect of LANCONONE in Weight-bearing Joint Pain

Vedic Lifesciences

Status: Completed

Conditions: Osteo Arthritis Knee

Treatments: Dietary Supplement: Methyl crystalline cellulose; Dietary Supplement: Lanconone®

Study type: Interventional

Funder types: Industry

Identifiers

NCT03658369

EB/180601/LANCONONE/PAIN

Details and patient eligibility

About

The current study has been designed to primarily assess the effect of Lanconone® in comparison to placebo on pain in weight bearing joints.

Enrollment: 72 patients

Sex: All

Ages: 40 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. BMI ≥ 25 and ≤ 29.9 kg/m2.
2. With unilateral or bilateral OA of the knee for at least greater than 3 months, as presented by pain in the knee at least for last 3 months.
3. Post-menopausal females (LMP at least 12 months prior to the screening).

Exclusion criteria

1. History of osteoarthritis for more than 3 years.
2. Systolic Blood Pressure ≥140 mm Hg and Diastolic Blood Pressure ≥ 90 mm Hg
3. FBS>140 mg/dl.
4. Smokers or chronic alcoholics.
5. Participants planning to travel in the next 56 days or engage in any non-routine activity that is likely to strain the knees.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

72 participants in 2 patient groups, including a placebo group

Lanconone®

Active Comparator group

Description:

Lanconone®: 2 Capsules once a day after breakfast

Treatment:

Dietary Supplement: Lanconone®

Methyl Crystalline Cellulose

Placebo Comparator group

Description:

2 Capsules once a day after breakfast

Treatment:

Dietary Supplement: Methyl crystalline cellulose